131 Evaluation of Hemoglobin Monitoring Frequency in Patients on Anticoagulation Therapy

Introduction: Major bleeding is the most notable risk associated with anticoagulation. Routine hemoglobin screening has been valuable in detecting occult bleeds but there is no clear designation on how often patients on anticoagulation therapy should be monitored and if this affects bleeding risk. The objective of this study was to compare outpatient hemoglobin monitoring intervals of less than and more than annually in patients on anticoagulation therapy.